Abstract
CD4+ T cells have been and are still largely regarded as the orchestrators of immune responses, being able to differentiate into distinct T helper cell populations based on differentiation signals, transcription factor expression, cytokine secretion, and specific functions. Nonetheless, a growing body of evidence indicates that CD4+ T cells can also exert a direct effector activity, which depends on intrinsic cytotoxic properties acquired and carried out along with the evolution of several pathogenic infections. The relevant role of CD4+ T cell lytic features in the control of such infectious conditions also leads to their exploitation as a new immunotherapeutic approach. This review aims at summarizing currently available data about functional and therapeutic relevance of cytotoxic CD4+ T cells in the context of viral infections and virus-driven tumors.
Author supplied keywords
Cite
CITATION STYLE
Muraro, E., Merlo, A., Martorelli, D., Cangemi, M., Santa, S. D., Dolcetti, R., & Rosato, A. (2017, February 27). Fighting viral infections and virus-driven tumors with cytotoxic CD4+ T cells. Frontiers in Immunology. Frontiers Research Foundation. https://doi.org/10.3389/fimmu.2017.00197
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.